Shareholding disclosure

HBM BioVentures AG

Declared position

2.98%

Threshold

Crossed upwards

Timeline

Published

21.11.2009

Transaction

16.11.2009

Transfer date

16.11.2009

Voting rights breakdown

Voting rights acquired2.98%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TA9BJ00037

Beneficial owner

HBM BioVentures AG

Declared address

HBM BioVentures AG, 6340 Baar

HBM BioVentures Ltd Cayman is totally controlled (100%) by HBM BioVentures AG

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

HBM BioVentures AG

Newron Pharmaceuticals S.p.A.21.11.2009TA9BJ00037

Disclosure summary

HBM BioVentures AG disclosed a holding in Newron Pharmaceuticals S.p.A. on the acquisition side, published by SIX Exchange Regulation on 21.11.2009, at 2.98% of voting rights. Notice category: Single shareholder.

Disclosed position

2.98%

Voting rights acquired

Voting rights acquired2.98%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

HBM BioVentures AG disclosed a holding in Newron Pharmaceuticals S.p.A., published on 21.11.2009.

Publication date21.11.2009

Transaction date16.11.2009

Transfer date16.11.2009

Issuing companyNewron Pharmaceuticals S.p.A.

Beneficial ownerHBM BioVentures AG

Declared addressHBM BioVentures AG, 6340 Baar

CategorySingle shareholder

Voting rights acquired2.98%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTA9BJ00037

Commercial register

CHE-101.849.760

Registered

Zefix record

Conditions

HBM BioVentures Ltd Cayman is totally controlled (100%) by HBM BioVentures AG

Source: SIX Exchange Regulation · Publication date: 21.11.2009

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open